| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 853,436 | 1,126,509 | 1,298,475 | 1,200,931 | | Cost of Revenue | 446,277 | 557,797 | 619,459 | 554,596 | | | Gross Profit | 407,159 | 568,712 | 679,016 | 646,335 | | | Operating Expenses | | Research Development | 372,724 | 382,666 | 379,279 | 380,035 | | Selling General and Administrative | 125,048 | 147,213 | 141,941 | 142,017 | | Non Recurring | 8,261 | 200,943 | 250 | 900 | | Others | 4,159 | 2,842 | 183 | 184 | | | | Total Operating Expenses | 510,192 | 733,664 | 521,653 | 523,136 | | | | Operating Income or Loss | (103,033) | (164,952) | 157,363 | 123,199 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,044 | 8,189 | 8,731 | 12,237 | | Earnings Before Interest And Taxes | (96,989) | (156,763) | 166,094 | 135,436 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (96,989) | (156,763) | 166,094 | 135,436 | | Income Tax Expense | (5,049) | 2,452 | 1,188 | 647 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (91,940) | (159,215) | 164,906 | 134,789 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (91,940) | (159,215) | 164,906 | 134,789 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($91,940) | ($159,215) | $164,906 | $134,789 |
|
0.45% Nasdaq 
0.20%
Income Statement
